As of 2026-06-12, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 0.87 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -2.55 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.1x - 5.7x | 3.4x |
| Forward P/E multiples | 0.5x - 1.5x | 0.7x |
| Fair Price | (0.04) - (0.02) | (0.04) |
| Upside | -344.8% - -262.1% | -340.5% |
| Date | EV/EBITDA |
| 2026-06-04 | -0.34 |
| 2026-06-02 | -0.34 |
| 2026-05-19 | -0.34 |
| 2026-05-14 | -0.34 |
| 2026-05-13 | -0.34 |
| 2026-05-05 | -0.11 |
| 2026-04-29 | -0.34 |
| 2026-04-16 | -0.34 |
| 2026-04-14 | -0.34 |
| 2026-04-13 | -0.34 |
| 2026-04-07 | -0.57 |
| 2026-03-31 | -0.57 |
| 2026-03-30 | -0.57 |
| 2026-03-20 | -0.34 |
| 2026-03-18 | -0.34 |